The Federal Communications Commission has voted to expand its technology crackdown on China, signaling that U.S. officials want tighter control not only over Chinese telecom
Intellia Therapeutics rose sharply after reporting successful late-stage results for its experimental gene-editing treatment for hereditary angioedema, a rare disorder that causes dangerous and recurring
Arizona’s PROTECT Act, introduced by Arizona State Representative Nick Kupper following outreach from Uldouz Wallace, is advancing toward final approval, marking a critical step in
Intellia Therapeutics rose sharply after reporting successful late-stage results for its experimental gene-editing treatment for hereditary angioedema, a rare disorder that causes dangerous and recurring
Moderna has begun a late-stage clinical trial of its experimental bird flu vaccine in the United States and the United Kingdom, marking a significant milestone
The Lucas Museum of Narrative Art has unveiled the first exhibitions visitors will see when the long-awaited Los Angeles institution opens on Sept. 22, and
Blue Owl Capital has agreed to acquire Sila Realty Trust in an all-cash deal valued at about $2.4 billion, expanding its push into healthcare real
The Lucas Museum of Narrative Art has unveiled the first exhibitions visitors will see when the long-awaited Los Angeles institution opens on Sept. 22, and
The Federal Communications Commission has voted to expand its technology crackdown on China, signaling that U.S. officials want tighter control not only over Chinese telecom
The New York Finance is the premier platform for bold innovation, visionary leadership, and next-generation entrepreneurship. Dive into compelling stories of emerging ventures, market game-changers, and influential leaders redefining the business landscape. Stay informed with exclusive rankings, strategic insights, and the key trends shaping the global financial future.
Never miss any important news. Subscribe to our newsletter.
Copyright 2026 - The New York Finance - All rights reserved.
Never miss any important news. Subscribe to our newsletter.
